<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Levensten Law Firm</title>
	<atom:link href="http://levenstenlawfirm.com/blog/?feed=rss2" rel="self" type="application/rss+xml" />
	<link>http://levenstenlawfirm.com/blog</link>
	<description>Scott Levensten, an attorney from Philadelphia, Pennsylvania handling injury lawsuits in all 50 states.</description>
	<lastBuildDate>Wed, 07 Dec 2011 23:31:03 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>Unsealed Bayer Documents In Lawsuits Show Yasmin Poses Significant Risk of Deep Vein Thrombosis and Pulmonary Embolism</title>
		<link>http://levenstenlawfirm.com/blog/?p=44</link>
		<comments>http://levenstenlawfirm.com/blog/?p=44#comments</comments>
		<pubDate>Wed, 07 Dec 2011 23:31:03 +0000</pubDate>
		<dc:creator>levensten</dc:creator>
				<category><![CDATA[Yaz Yasmin Ocella Side Effects]]></category>
		<category><![CDATA[Yasmin Deep Vein Thrombosis]]></category>
		<category><![CDATA[Yasmin Injury]]></category>
		<category><![CDATA[Yasmin Lawsuits]]></category>
		<category><![CDATA[Yasmin Pulmonary Embolism]]></category>
		<category><![CDATA[Yaz Deep Vein Thrombosis]]></category>
		<category><![CDATA[Yaz Injury]]></category>
		<category><![CDATA[Yaz Lawsuits]]></category>
		<category><![CDATA[Yaz Pulmonary Embolism]]></category>

		<guid isPermaLink="false">http://levenstenlawfirm.com/blog/?p=44</guid>
		<description><![CDATA[     As we reported in a previous blog, tomorrow the FDA will be considering safety findings on Yasmin and Yaz, but will not be armed with some alarming data Bayer apparently withheld from U.S. regulators.      The former head of the FDA, David Kessler, stated in a document unsealed yesterday by the MDL court in [...]]]></description>
		<wfw:commentRss>http://levenstenlawfirm.com/blog/?feed=rss2&#038;p=44</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Transvaginal Mesh and Vaginal Sling Products Pose a Risk of Serious Injury from Life-Threatening Side Effects</title>
		<link>http://levenstenlawfirm.com/blog/?p=41</link>
		<comments>http://levenstenlawfirm.com/blog/?p=41#comments</comments>
		<pubDate>Wed, 07 Dec 2011 21:02:58 +0000</pubDate>
		<dc:creator>levensten</dc:creator>
				<category><![CDATA[Transvaginal Mesh]]></category>
		<category><![CDATA[Transvaginal mesh Injury]]></category>
		<category><![CDATA[Transvaginal Mesh Lawsuits]]></category>
		<category><![CDATA[Transvaginal Mesh Lawyer]]></category>
		<category><![CDATA[Vaginal Sling Injury]]></category>

		<guid isPermaLink="false">http://levenstenlawfirm.com/blog/?p=41</guid>
		<description><![CDATA[     For women experiencing Pelvic Organ Prolapse (POP) or Stress Urinary Incontinence (SUI), placement of transvaginal surgical mesh was intended to help reinforce the weakened vaginal or urethral walls.  Ideally, the permanently implanted surgical mesh would repair POP and/or treat urinary incontinence.      In 2008 the United States Food and Drug Administration (FDA) noticed that [...]]]></description>
		<wfw:commentRss>http://levenstenlawfirm.com/blog/?feed=rss2&#038;p=41</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Merck Failed to Adequately Warn That Propecia is Associated With Permanent Impotence, Erectile Dysfunction, Depression, Endocrine Crash and Other Harmful Side Effects</title>
		<link>http://levenstenlawfirm.com/blog/?p=37</link>
		<comments>http://levenstenlawfirm.com/blog/?p=37#comments</comments>
		<pubDate>Mon, 05 Dec 2011 19:01:07 +0000</pubDate>
		<dc:creator>levensten</dc:creator>
				<category><![CDATA[Propecia]]></category>
		<category><![CDATA[Endocrine Crash]]></category>
		<category><![CDATA[Propecia Erectile Dysfunction]]></category>
		<category><![CDATA[Propecia Impotence]]></category>
		<category><![CDATA[Propecia Lawsuit]]></category>
		<category><![CDATA[Propecia Lawyer]]></category>
		<category><![CDATA[Propecia Side Effects]]></category>

		<guid isPermaLink="false">http://levenstenlawfirm.com/blog/?p=37</guid>
		<description><![CDATA[     The Levensten Law Firm is currently investigating the filing of Propecia lawsuits against Merck for its failure to adequately warn of Propecia’s harmful side effects.  Studies show that Propecia is associated with permanent impotence, erectile dysfunction, depression, endocrine crash and other harmful side effects.      By way of background, Propecia is marketed to treat [...]]]></description>
		<wfw:commentRss>http://levenstenlawfirm.com/blog/?feed=rss2&#038;p=37</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bayer Attacks Philadelphia County Mass Tort Program Seeking to Scatter Yaz Victims’ Cases Across The Country to Gain Advantage in Yaz Litigation</title>
		<link>http://levenstenlawfirm.com/blog/?p=34</link>
		<comments>http://levenstenlawfirm.com/blog/?p=34#comments</comments>
		<pubDate>Sun, 04 Dec 2011 15:07:17 +0000</pubDate>
		<dc:creator>levensten</dc:creator>
				<category><![CDATA[Yaz Yasmin Ocella Side Effects]]></category>
		<category><![CDATA[Ocella]]></category>
		<category><![CDATA[Yasmin]]></category>
		<category><![CDATA[Yasmin Deep Vein Thrombosis]]></category>
		<category><![CDATA[Yasmin Lawsuit]]></category>
		<category><![CDATA[Yasmin Lawyer]]></category>
		<category><![CDATA[Yasmin Pulmonary Embolism]]></category>
		<category><![CDATA[Yaz]]></category>
		<category><![CDATA[Yaz Deep Vein Thrombosis]]></category>
		<category><![CDATA[Yaz Lawsuit]]></category>
		<category><![CDATA[Yaz Lawyer]]></category>
		<category><![CDATA[Yaz Pulmonary Embolism]]></category>

		<guid isPermaLink="false">http://levenstenlawfirm.com/blog/?p=34</guid>
		<description><![CDATA[     In an effort to gain an advantage in the Yaz, Yasmin and Ocella personal injury litigation, Bayer launched an assault on the Philadelphia County Mass Tort program and the experienced judges who administer it. Bayer recently filed a King’s Bench petition asking the Pennsylvania Supreme Court  to hold that the Philadelphia County Mass Tort [...]]]></description>
		<wfw:commentRss>http://levenstenlawfirm.com/blog/?feed=rss2&#038;p=34</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An Explanation of How Actos Lawsuits Are Handled In State Courts and Federal Courts</title>
		<link>http://levenstenlawfirm.com/blog/?p=30</link>
		<comments>http://levenstenlawfirm.com/blog/?p=30#comments</comments>
		<pubDate>Sun, 13 Nov 2011 16:09:11 +0000</pubDate>
		<dc:creator>levensten</dc:creator>
				<category><![CDATA[Actos and Bladder Cancer]]></category>
		<category><![CDATA[Actos Bladder Cancer]]></category>
		<category><![CDATA[Actos Claim]]></category>
		<category><![CDATA[Actos Help]]></category>
		<category><![CDATA[Actos Law Firm]]></category>
		<category><![CDATA[Actos Lawsuits]]></category>
		<category><![CDATA[Actos Lawyers]]></category>
		<category><![CDATA[Actos Litigation]]></category>
		<category><![CDATA[Actos Multidistrict Litigation]]></category>
		<category><![CDATA[Actos Settlements]]></category>
		<category><![CDATA[Actos Side Effects]]></category>
		<category><![CDATA[Actos Victims]]></category>

		<guid isPermaLink="false">http://levenstenlawfirm.com/blog/?p=30</guid>
		<description><![CDATA[     Earlier this year, the public was alerted that the diabetes medication, Actos, causes bladder cancer.  It did not take long for the FDA and the public to discover that the manufacturer of Actos tragically failed to adequately warn and properly study the risk of bladder cancer.  Takeda, the manufacturer of Actos, deprived physicians of [...]]]></description>
		<wfw:commentRss>http://levenstenlawfirm.com/blog/?feed=rss2&#038;p=30</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Background Information about Actos and Bladder Cancer</title>
		<link>http://levenstenlawfirm.com/blog/?p=27</link>
		<comments>http://levenstenlawfirm.com/blog/?p=27#comments</comments>
		<pubDate>Sun, 13 Nov 2011 15:55:42 +0000</pubDate>
		<dc:creator>levensten</dc:creator>
				<category><![CDATA[Actos and Bladder Cancer]]></category>
		<category><![CDATA[Actos]]></category>
		<category><![CDATA[Actos Lawsuits]]></category>
		<category><![CDATA[Actos Lawyers]]></category>
		<category><![CDATA[Actos Settlements]]></category>
		<category><![CDATA[Actos Side Effects]]></category>
		<category><![CDATA[Bladder Cancer]]></category>

		<guid isPermaLink="false">http://levenstenlawfirm.com/blog/?p=27</guid>
		<description><![CDATA[ACTOS ASSOCIATION WITH BLADDER CANCER           In 1999 with Actos received FDA approval to treat type II diabetes.  Before getting approval for Actos, Takeda knew that it would cause casastrophic side effects, including bladder cancer.  Animal studies showed a signal for bladder cancer risk.  Takeda knew that they should have  studied the bladder cancer risk further.  Bladder [...]]]></description>
		<wfw:commentRss>http://levenstenlawfirm.com/blog/?feed=rss2&#038;p=27</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Important Details About FDA&#8217;s Dec. 8, 2011 Meeting About Birth Control Such As Yaz and Yasmin</title>
		<link>http://levenstenlawfirm.com/blog/?p=20</link>
		<comments>http://levenstenlawfirm.com/blog/?p=20#comments</comments>
		<pubDate>Fri, 11 Nov 2011 15:04:48 +0000</pubDate>
		<dc:creator>levensten</dc:creator>
				<category><![CDATA[Yaz Yasmin Ocella Side Effects]]></category>
		<category><![CDATA[Yasmin Bloodclot]]></category>
		<category><![CDATA[Yasmin Deep Vein Thrombosis]]></category>
		<category><![CDATA[Yasmin FDA]]></category>
		<category><![CDATA[Yasmin Lawsuit]]></category>
		<category><![CDATA[Yasmin Pulmonary Embolism]]></category>
		<category><![CDATA[Yaz Blood Clot]]></category>
		<category><![CDATA[Yaz Deep Vein Thrombosis]]></category>
		<category><![CDATA[Yaz FDA]]></category>
		<category><![CDATA[Yaz Lawsuit]]></category>
		<category><![CDATA[Yaz Pulmonary Embolism]]></category>

		<guid isPermaLink="false">http://levenstenlawfirm.com/blog/?p=20</guid>
		<description><![CDATA[     The FDA&#8217;s joint meeting of  the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee will be held on December 8, 2011, from 8 a.m. to 5 p.m.  The location is The Marriott Inn and Conference Center, University of Maryland University College, The Ballroom, 3501 University Blvd. East, Adelphi, MD. [...]]]></description>
		<wfw:commentRss>http://levenstenlawfirm.com/blog/?feed=rss2&#038;p=20</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Posts Questions and Answers About Increased Risks of Blood Clots With Birth Control Like Yaz and Yasmin</title>
		<link>http://levenstenlawfirm.com/blog/?p=14</link>
		<comments>http://levenstenlawfirm.com/blog/?p=14#comments</comments>
		<pubDate>Fri, 04 Nov 2011 00:03:49 +0000</pubDate>
		<dc:creator>levensten</dc:creator>
				<category><![CDATA[Yaz Yasmin Ocella Side Effects]]></category>
		<category><![CDATA[Yasmin]]></category>
		<category><![CDATA[Yasmin Deep Vein Thrombosis]]></category>
		<category><![CDATA[Yasmin Injury]]></category>
		<category><![CDATA[Yasmin Lawsuit]]></category>
		<category><![CDATA[Yasmin Pulmonary Embolism]]></category>
		<category><![CDATA[Yaz]]></category>
		<category><![CDATA[Yaz Deep Vein Thrombosis]]></category>
		<category><![CDATA[Yaz Injury]]></category>
		<category><![CDATA[Yaz Lawsuit]]></category>
		<category><![CDATA[Yaz Pulmonary Embolism]]></category>

		<guid isPermaLink="false">http://levenstenlawfirm.com/blog/?p=14</guid>
		<description><![CDATA[The FDA has posted questions and answers that provide a safety overview of Yaz and Yasmin. The link to the questions and answers is: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm273039.htm The FDA provides answers to the following questions: Q1. What is drospirenone? Q2. Which birth control pills (oral contraceptives) contain drospirenone? Q3. What is a venous thromboembolic event (VTE)? Q4. [...]]]></description>
		<wfw:commentRss>http://levenstenlawfirm.com/blog/?feed=rss2&#038;p=14</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA To Hold Meeting on December 8, 2011 About Safety of Yaz and Yasmin</title>
		<link>http://levenstenlawfirm.com/blog/?p=10</link>
		<comments>http://levenstenlawfirm.com/blog/?p=10#comments</comments>
		<pubDate>Sun, 30 Oct 2011 12:07:58 +0000</pubDate>
		<dc:creator>levensten</dc:creator>
				<category><![CDATA[Yaz Yasmin Ocella Side Effects]]></category>
		<category><![CDATA[Yaz, Yasmin, Yaz Recall, Yaz Side Effects, Yaz Lawsuit, Yaz Lawyers, FDA]]></category>

		<guid isPermaLink="false">http://levenstenlawfirm.com/blog/?p=10</guid>
		<description><![CDATA[On December 8, 2011, the FDA is holding a meeting of the Reproductive Health Drugs Advisory Committee and the Drug and Safety Risk Management Committee to discuss the risk of blood clots in drugs such as Yaz and Yasmin that contain drospirenone. This is on the heels of the release of the FDA’s study showing [...]]]></description>
		<wfw:commentRss>http://levenstenlawfirm.com/blog/?feed=rss2&#038;p=10</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Landmark Study on the risks of Birth control such as Yaz, Yasmin, Ocella, Nuvaring and Ortho Evra</title>
		<link>http://levenstenlawfirm.com/blog/?p=7</link>
		<comments>http://levenstenlawfirm.com/blog/?p=7#comments</comments>
		<pubDate>Fri, 28 Oct 2011 15:12:30 +0000</pubDate>
		<dc:creator>levensten</dc:creator>
				<category><![CDATA[Yaz Yasmin Ocella Side Effects]]></category>
		<category><![CDATA[Deep Vein Thrombosis]]></category>
		<category><![CDATA[Heart Attack]]></category>
		<category><![CDATA[Nuvaring]]></category>
		<category><![CDATA[Ortho Evra]]></category>
		<category><![CDATA[Pulmonary Embolism]]></category>
		<category><![CDATA[Stroke]]></category>
		<category><![CDATA[Yasmin]]></category>
		<category><![CDATA[Yaz]]></category>

		<guid isPermaLink="false">http://levenstenlawfirm.com/blog/?p=7</guid>
		<description><![CDATA[Breaking news was released from the FDA this morning concerning a landmark study of the risk of arterial and venous cardiovascular complications caused by Yaz, Yasmin and Ocella. Until now, there was limited data available regarding the risk of venus thromboembolism (VTE) (deep venous thrombosis [DVT] and pulmonary embolism [PE]) in combined hormonal contraceptives (CHCs), [...]]]></description>
		<wfw:commentRss>http://levenstenlawfirm.com/blog/?feed=rss2&#038;p=7</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

